XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 5,157 $ 4,790
Accounts receivable, net 2,505 2,346
Inventory 425 230
Deferred offering costs 283
Prepaid expenses 1,289 1,452
Other current assets 746 801
Total current assets 10,122 9,902
Non-current assets:    
Property and equipment, net 2 12
Right-of-use assets 1,971 778
Total Assets 12,095 10,692
Commitments and contingencies (Note 8)
Current liabilities:    
Accounts payable 4,035 2,683
Accrued expenses 3,210 4,300
Deferred revenue 960 2,311
Lease liabilities, short-term 201 853
Notes payable 422 436
Notes payable – at fair value 2,365
Warrant liabilities 6,451 1,818
Total current liabilities 17,644 12,401
Lease liabilities, long-term 1,702
Total Liabilities 19,346 12,401
Stockholders’ Deficit    
Preferred stock ($0.0001 par value); 1,000,000 shares authorized; no shares issued and outstanding as of December 31, 2024 and December 31, 2023
Common stock ($0.0001 par value); 80,000,000 shares authorized; 22,594,877 and 16,294,935 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively 2 2
Additional paid-in capital 40,847 31,065
Accumulated other comprehensive income 3 12
Accumulated deficit (48,103) (32,788)
Total Stockholders’ Deficit (7,251) (1,709)
Total Liabilities and Stockholders’ Deficit $ 12,095 $ 10,692